BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 11316070)

  • 1. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.
    Nikolova Z; Hof A; Baumlin Y; Hof RP
    Transpl Immunol; 2001 Feb; 8(4):267-77. PubMed ID: 11316070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD.
    Nikolova Z; Hof A; Baumlin Y; Hof RP
    Transpl Immunol; 2000 Jun; 8(2):115-24. PubMed ID: 11005317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined FTY720/cyclosporine treatment promotes graft survival and lowers the peripheral lymphocyte count in a murine cardiac allotransplantation model.
    Nikolova Z; Hof A; Baumlin Y; Hof RP
    Transplantation; 2001 Jul; 72(1):168-71. PubMed ID: 11468555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of SDZ RAD compared with CsA monotherapyand combined Rad/FTY720 treatment in a murine cardiac allotransplantation model.
    Nikolova Z; Hof A; Baumlin Y; Hof RP
    Transpl Immunol; 2001 Oct; 9(1):43-9. PubMed ID: 11680571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.
    Sakagawa T; Kiyochi H; Honda K; Kobayashi N
    Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
    Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
    Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine.
    Troncoso P; Stepkowski SM; Wang ME; Qu X; Chueh SC; Clark J; Kahan BD
    Transplantation; 1999 Jan; 67(1):145-51. PubMed ID: 9921811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of mycophenolate sodium as monotherapy and in combination with FTY720 in a DA-to-Lewis-rat heart-transplantation model.
    Matsumoto Y; Hof A; Baumlin Y; Hof RP
    Transplantation; 2002 Nov; 74(10):1372-6. PubMed ID: 12451233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR; Silva LB; Cury PM; Burdmann EA; Bueno V
    Int Immunopharmacol; 2006 Dec; 6(13-14):1911-8. PubMed ID: 17161344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of graft vessel disease by combined FTY720/cyclosporine. A treatment in a rat carotid artery transplantation model.
    Nikolova Z; Hof A; Rudin M; Baumlin Y; Kraus G; Hof RP
    Transplantation; 2000 Jun; 69(12):2525-30. PubMed ID: 10910272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD.
    Schuurman HJ; Menninger K; Audet M; Kunkler A; Maurer C; Vedrine C; Bernhard M; Gaschen L; Brinkmann V; Quesniaux V
    Transplantation; 2002 Oct; 74(7):951-60. PubMed ID: 12394836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate.
    Chiba K; Hoshino Y; Ohtsuki M; Kataoka H; Maeda Y; Matsuyuki H; Sugahara K; Kiuchi M; Hirose R; Adachi K
    Transplant Proc; 2005; 37(1):102-6. PubMed ID: 15808561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolongation of concordant xenograft survival by treatment with FTY720.
    Miyata Y; Ohdan H; Noriyuki T; Shintaku S; Shibata S; Yamamoto H; Fan XH; Fudaba Y; Yoshioka S; Asahara T; Fukuda Y; Dohi K
    Transplant Proc; 1998 Dec; 30(8):4163-5. PubMed ID: 9865334
    [No Abstract]   [Full Text] [Related]  

  • 15. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
    Yanagawa Y; Sugahara K; Kataoka H; Kawaguchi T; Masubuchi Y; Chiba K
    J Immunol; 1998 Jun; 160(11):5493-9. PubMed ID: 9605152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720: effect of monotherapy and combined treatment with conventional drugs.
    Furukawa H; Suzuki T; Jin MB; Yamashita K; Taniguchi M; Magata S; Ishikawa H; Ogata K; Masuko H; Shimamura T; Fukai M; Hayashi T; Fujita M; Nagashima K; Omura T; Kishida A; Todo S
    Transplantation; 2000 Jan; 69(2):235-41. PubMed ID: 10670633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T; Van Damme B; Rutgeerts O; Waer M; Pirenne J
    Transplantation; 2003 Apr; 75(7):945-52. PubMed ID: 12698078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTY720, a new immunosuppressant, as rescue therapy in mouse cardiac transplantation.
    Wang MH; Milekhin V; Zhang H; Huang HZ
    Acta Pharmacol Sin; 2003 Sep; 24(9):847-52. PubMed ID: 12956930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel immunosuppressant FTY720 induces peripheral lymphodepletion of both T- and B-cells in cynomolgus monkeys when given alone, with Cyclosporine Neoral or with RAD.
    Quesniaux VF; Menninger K; Kunkler A; Vedrine C; Bernhard M; Hedinger R; Kraus G; Schuurman HJ
    Transpl Immunol; 2000 Nov; 8(3):177-87. PubMed ID: 11147698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720.
    Chueh SC; Tian L; Wang M; Wang ME; Stepkowski SM; Kahan BD
    Transplantation; 1997 Nov; 64(10):1407-14. PubMed ID: 9392303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.